These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 11378969)
1. Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens. Schultze JL; Maecker B; von Bergwelt-Baildon MS; Anderson KS; Vonderheide RH Vox Sang; 2001 Feb; 80(2):81-9. PubMed ID: 11378969 [TBL] [Abstract][Full Text] [Related]
2. [Immunotherapy: new insights]. Geissler M; Weth R Praxis (Bern 1994); 2002 Dec; 91(51-52):2236-46. PubMed ID: 12564040 [TBL] [Abstract][Full Text] [Related]
3. Telomerase as a universal tumor antigen for cancer vaccines. Beatty GL; Vonderheide RH Expert Rev Vaccines; 2008 Sep; 7(7):881-7. PubMed ID: 18767939 [TBL] [Abstract][Full Text] [Related]
4. DNA vaccine for cancer immunotherapy. Yang B; Jeang J; Yang A; Wu TC; Hung CF Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927 [TBL] [Abstract][Full Text] [Related]
5. Innovative cancer vaccine strategies based on the identification of tumour-associated antigens. Ying H; Zeng G; Black KL BioDrugs; 2001; 15(12):819-31. PubMed ID: 11784213 [TBL] [Abstract][Full Text] [Related]
6. Cancer immunotherapy targeting the telomerase reverse transcriptase. Huo LF; Tang JW; Huang JJ; Huang PT; Huang CF; Kung HF; Lin MC Cell Mol Immunol; 2006 Feb; 3(1):1-11. PubMed ID: 16549043 [TBL] [Abstract][Full Text] [Related]
7. Telomerase in cancer immunotherapy. Liu JP; Chen W; Schwarer AP; Li H Biochim Biophys Acta; 2010 Jan; 1805(1):35-42. PubMed ID: 19751801 [TBL] [Abstract][Full Text] [Related]
8. Antigen-specific vaccines for cancer treatment. Tagliamonte M; Petrizzo A; Tornesello ML; Buonaguro FM; Buonaguro L Hum Vaccin Immunother; 2014; 10(11):3332-46. PubMed ID: 25483639 [TBL] [Abstract][Full Text] [Related]
9. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy. Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828 [TBL] [Abstract][Full Text] [Related]
10. T cell-mediated immunotherapy of metastases: state of the art in 2005. Schirrmacher V Expert Opin Biol Ther; 2005 Aug; 5(8):1051-68. PubMed ID: 16050783 [TBL] [Abstract][Full Text] [Related]
11. Strategies in cancer vaccines development. Cunto-Amesty G; Monzavi-Karbassi B; Luo P; Jousheghany F; Kieber-Emmons T Int J Parasitol; 2003 May; 33(5-6):597-613. PubMed ID: 12782058 [TBL] [Abstract][Full Text] [Related]
12. Immunobiology and gene-based immunotherapy of hepatocellular carcinoma. Geissler M; Mohr L; Ali MY; Grimm CF; Ritter M; Blum HE Z Gastroenterol; 2003 Nov; 41(11):1101-10. PubMed ID: 14648380 [TBL] [Abstract][Full Text] [Related]
13. Introduction. Garrido F Adv Exp Med Biol; 2019; 1151():1-14. PubMed ID: 31140105 [TBL] [Abstract][Full Text] [Related]
14. Glioma antigen. Toda M Adv Exp Med Biol; 2012; 746():77-84. PubMed ID: 22639160 [TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit. Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932 [TBL] [Abstract][Full Text] [Related]
17. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases]. Jäger E; Jäger D; Knuth A Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776 [No Abstract] [Full Text] [Related]